AIMC Topic: Drug Discovery

Clear Filters Showing 1151 to 1160 of 1567 articles

Prediction of selective estrogen receptor beta agonist using open data and machine learning approach.

Drug design, development and therapy
BACKGROUND: Estrogen receptors (ERs) are nuclear transcription factors that are involved in the regulation of many complex physiological processes in humans. ERs have been validated as important drug targets for the treatment of various diseases, inc...

A renaissance of neural networks in drug discovery.

Expert opinion on drug discovery
INTRODUCTION: Neural networks are becoming a very popular method for solving machine learning and artificial intelligence problems. The variety of neural network types and their application to drug discovery requires expert knowledge to choose the mo...

Machine Learning Model Analysis and Data Visualization with Small Molecules Tested in a Mouse Model of Mycobacterium tuberculosis Infection (2014-2015).

Journal of chemical information and modeling
The renewed urgency to develop new treatments for Mycobacterium tuberculosis (Mtb) infection has resulted in large-scale phenotypic screening and thousands of new active compounds in vitro. The next challenge is to identify candidates to pursue in a ...

Design of Biomedical Robots for Phenotype Prediction Problems.

Journal of computational biology : a journal of computational molecular cell biology
Genomics has been used with varying degrees of success in the context of drug discovery and in defining mechanisms of action for diseases like cancer and neurodegenerative and rare diseases in the quest for orphan drugs. To improve its utility, accur...

Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?

Expert opinion on drug discovery
INTRODUCTION: Artificial neural networks (ANNs) are highly adaptive nonlinear optimization algorithms that have been applied in many diverse scientific endeavors, ranging from economics, engineering, physics, and chemistry to medical science. Notably...

Toward High-Throughput Predictive Modeling of Protein Binding/Unbinding Kinetics.

Journal of chemical information and modeling
One of the unaddressed challenges in drug discovery is that drug potency determined in vitro is not a reliable indicator of drug activity in vivo. Accumulated evidence suggests that in vivo activity is more strongly correlated with the binding/unbind...

Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples.

IEEE/ACM transactions on computational biology and bioinformatics
Prediction of compound-protein interactions (CPIs) is to find new compound-protein pairs where a protein is targeted by at least a compound, which is a crucial step in new drug design. Currently, a number of machine learning based methods have been d...

Applications of Deep Learning in Biomedicine.

Molecular pharmaceutics
Increases in throughput and installed base of biomedical research equipment led to a massive accumulation of -omics data known to be highly variable, high-dimensional, and sourced from multiple often incompatible data platforms. While this data may b...

Application of an automated natural language processing (NLP) workflow to enable federated search of external biomedical content in drug discovery and development.

Drug discovery today
External content sources such as MEDLINE(®), National Institutes of Health (NIH) grants and conference websites provide access to the latest breaking biomedical information, which can inform pharmaceutical and biotechnology company pipeline decisions...

Physicochemical property profile for brain permeability: comparative study by different approaches.

Journal of drug targeting
A comparative study of classification models of brain penetration by different approaches was carried out on a training set of 1000 chemicals and drugs, and an external test set of 100 drugs. Ten approaches were applied in this work: seven medicinal ...